Network origin in Yasutoshi Kawakami first degree
Entity | Entity type | Industry | |
---|---|---|---|
Subsidiary | Pharmaceuticals: Other | 13 | |
Subsidiary | Biotechnology | 10 | |
Mitsubishi Tanabe Pharma America, Inc.
Mitsubishi Tanabe Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Part of Mitsubishi Chemical Group Corp., Mitsubishi Tanabe Pharma America, Inc. (MTPA) is a pharmaceutical company based in Jersey City, NJ. MTPA is a wholly-owned subsidiary of Mitsubishi Tanabe Pharma Corporation (MTPC) and was established to develop and advance their pipeline as well as commercialize approved pharmaceutical products in the United States. MTPA delivers innovative solutions that are guided by patients' unmet medical needs.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Yasutoshi Kawakami via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Medicago, Inc.
Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | Biotechnology | Director/Board Member | |
Mitsubishi Chemical Corp.
Mitsubishi Chemical Corp. Chemicals: Major DiversifiedProcess Industries Mitsubishi Chemical Corp. engages in the manufacture and sale of performance products and industrial materials. Its products and materials are used in automobiles and aircrafts; packaging, labels and films; IT, electronics and displays; environment and energy; and medical, food and bio products. The company was founded on August 31, 1933 and is headquartered in Tokyo, Japan. | Chemicals: Major Diversified | Director/Board Member | |
SANTEN PHARMACEUTICAL CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
Oridion Systems Ltd.
Oridion Systems Ltd. Medical SpecialtiesHealth Technology Oridion Systems Ltd. develops medical devices for patient safety monitoring. It produces medical devices (hardware) and patient interfaces (consumables) based on its patented Microstream and Smart Capnography technologies for the enhancement of patient safety and clinical outcomes. It provides solutions for respiratory monitoring and airway management for patients which includes non-incubated patients, premature newborns and clinical environments which includes procedural sedation, pain management, critical care units, post-anesthesia care units, emergency medical services, transport and alternate care. It operates in Jerusalem, Israel, Needham, Massachusetts and the United States of America. The company was founded by Yacov Bubis in 1987 and is headquartered in Jerusalem, Israel. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
Osaka University | College/University | Doctorate Degree | |
The Hebrew University of Jerusalem | College/University | Undergraduate Degree Doctorate Degree | |
MITSUBISHI CHEMICAL GROUP CORPORATION | Chemicals: Major Diversified | Comptroller/Controller/Auditor Chief Tech/Sci/R&D Officer | |
Kobe University | College/University | Masters Business Admin | |
Kyoto University | College/University | Undergraduate Degree | |
Kanazawa University | College/University | Undergraduate Degree | |
Santen, Inc.
Santen, Inc. Medical SpecialtiesHealth Technology Part of Santen Pharmaceutical Co., Ltd., Santen, Inc. is a company that develops ophthalmic products. The company is based in Emeryville, CA. The company was founded in 1993 by Adrienne L. Graves. Tatsuya Kaihara has been the CEO of the company since 2017. | Medical Specialties | Chief Executive Officer | |
B. GAON HOLDINGS LTD. | Financial Conglomerates | Director/Board Member | |
SanBio, Inc.
SanBio, Inc. Medical/Nursing ServicesHealth Services SanBio, Inc. develops regenerative therapies for neurological disorders. The firm is focused on cell therapies for neurological disorders such as stroke, traumatic brain injury, eye disease, and Parkinson's disease. Its product pipeline includes SB623 and SB618. The company was founded by Keita Mori and Toru Kawanishi in 2001 and is headquartered in Mountain View, CA. | Medical/Nursing Services | Chief Executive Officer | |
MP Healthcare Venture Management, Inc.
MP Healthcare Venture Management, Inc. Investment ManagersFinance MP Healthcare Venture Management, Inc (MP Healthcare Venture) is a venture capital subsidiary of Mitsubishi Tanabe Pharma Corp founded in 2006. The firm is headquartered in Boston, Massachusetts. | Investment Managers | President Director/Board Member | |
Teva Pharmaceuticals Ltd.
Teva Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals Ltd. manufactures pharmaceutical products. The company was incorporated on October 19, 1972 and is headquartered in Castleford, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
COLLPLANT BIOTECHNOLOGIES LTD. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
The Kaiteki Institute, Inc.
The Kaiteki Institute, Inc. Miscellaneous Commercial ServicesCommercial Services The Kaiteki Institute, Inc. engages in the research and investigation of social trends. It also involves in the research and development of new enterprises and operation and management of contract research. The company was founded on April 1, 2009 and is headquartered in Tokyo, Japan. | Miscellaneous Commercial Services | Director/Board Member | |
Mitsubishi Chemical Holdings America, Inc.
Mitsubishi Chemical Holdings America, Inc. Chemicals: Major DiversifiedProcess Industries Part of Mitsubishi Chemical Group Corp., Mitsubishi Chemical Holdings America, Inc. is a company that manufactures and supplies chemical products. The company is based in New York, NY. | Chemicals: Major Diversified | Chief Executive Officer | |
SANBIO COMPANY LIMITED | Pharmaceuticals: Major | Chief Operating Officer | |
Mitsubishi Tanabe Pharma Canada, Inc.
Mitsubishi Tanabe Pharma Canada, Inc. Pharmaceuticals: MajorHealth Technology Part of Mitsubishi Chemical Group Corp., Mitsubishi Tanabe Pharma Canada, Inc. is a Canadian pharmaceutical company founded in 2018. The company is based in Toronto, Canada. The company delivers innovative solutions that are guided by patients' unmet medical needs. | Pharmaceuticals: Major | President Chief Operating Officer |
Statistics
International
Japan | 10 |
Israel | 5 |
United States | 5 |
Canada | 3 |
United Kingdom | 2 |
Sectoral
Health Technology | 9 |
Consumer Services | 6 |
Process Industries | 5 |
Finance | 3 |
Health Services | 2 |
Operational
Director/Board Member | 20 |
Corporate Officer/Principal | 7 |
Chief Executive Officer | 7 |
Chief Tech/Sci/R&D Officer | 5 |
President | 5 |
Most connected contacts
Insiders | |
---|---|
Akihiro Tsujimura | 7 |
Ken Fujiwara | 5 |
Uri David | 3 |
Tak Mukohira | 3 |
Elana Gazal | 3 |
Naoya Sato | 3 |
Ziva Mesika | 3 |
Atsushi Fujimoto | 2 |
Matsuo Kikuchi | 2 |
Ryosuke Tanabe | 2 |
Larry Meixner | 2 |
Sam Shum | 2 |
Hiroaki Ueno | 2 |
Anat Nahmany | 1 |
Kengo Isshiki | 1 |
- Stock Market
- Insiders
- Yasutoshi Kawakami
- Company connections